×
| Date | Author | Type | Reco Price | Target Price | Potential | Source | PDF Link |
|---|---|---|---|---|---|---|---|
| 25 Apr 2024 | Asit C. Mehta | Buy | ₹1,357 | ₹1,675 | -27.5% | moneycontrol | View |
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd., | 2.95 | -1.93 | NA | -7.86 | 0 | |
| CAPLIN POINT LABORATORIES LTD. | 5,644.10 | 1,602.30 | 5,340.40 | 20.25 | 15,483 | 27.4 |
| NATCO PHARMA LTD. | 13576.0 | 5009.0 | 12643.0 | 27.97 | 14700 | 8.66 |
| Rainbow Children's Medicare Li | 4529.94 | 756.24 | 4447.99 | 7.41 | 13830 | 53.7 |
Caplin Point Laboratories Ltd., with Security Code 524742, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 132.8 | 139.4 | 185.6 | 207.9 | 185.2 | 173.6 | 182.6 | 175.2 |
| Expenses | 69.5 | 81.7 | 104.3 | 109.8 | 107.8 | 98.6 | 96.0 | 99.3 |
| Operating Profit | 63.3 | 57.7 | 81.4 | 98.2 | 77.4 | 75.0 | 86.6 | 75.9 |
| OPM % | 47.67% | 41.38% | 43.84% | 47.21% | 41.78% | 43.22% | 47.44% | 43.3% |
| Other Income | 17.9 | 36.2 | 21.5 | 43.0 | 28.8 | 41.3 | 32.0 | 59.2 |
| Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
| Depreciation | 6.8 | 6.9 | 6.2 | 6.5 | 6.0 | 6.1 | 6.1 | 6.0 |
| Profit before tax | 74.4 | 86.9 | 96.7 | 134.7 | 100.2 | 110.2 | 112.5 | 129.0 |
| Tax % | -25.5% | -19.6% | -25% | -21.5% | -25.4% | -21.4% | 23.6% | 20.5% |
| Net Profit | 55.5 | 69.9 | 72.5 | 105.7 | 74.7 | 86.5 | 85.9 | 102.6 |
| EPS in Rs | 7.29 | 9.14 | 9.5 | 13.85 | 9.77 | 0 | 11.26 | 13.45 |
| Metrics | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 410.1 | 435.5 | 453.2 | 459.0 | 483.1 | 493.0 | 502.5 | 534.0 |
| Expenses | 272.7 | 293.2 | 308.0 | 307.2 | 318.4 | 330.7 | 334.4 | 344.9 |
| Operating Profit | 137.4 | 142.3 | 145.2 | 151.8 | 164.7 | 162.3 | 168.1 | 189.2 |
| OPM % | 33.51% | 32.67% | 32.04% | 33.08% | 34.08% | 32.92% | 33.45% | 35.42% |
| Other Income | 20.4 | 17.2 | 17.4 | 18.6 | 20.8 | 31.4 | 25.7 | 30.4 |
| Interest | 0.2 | 0.2 | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 |
| Depreciation | 11.8 | 13.9 | 16.4 | 16.0 | 16.8 | 16.2 | 17.0 | 18.4 |
| Profit before tax | 145.9 | 145.4 | 146.0 | 154.4 | 168.5 | 177.3 | 176.6 | 201.0 |
| Tax % | -20.5% | -17.6% | -17% | -19.1% | -22.3% | -21% | -17.7% | -20.3% |
| Net Profit | 116.1 | 119.8 | 121.2 | 124.9 | 130.8 | 140.1 | 145.3 | 160.2 |
| EPS in Rs | 15.06 | 15.39 | 15.9 | 16.24 | 17.12 | 18.19 | 0 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 7% |
| 3 Years: | 13% |
| TTM: | 20% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 29% |
| 5 Years: | 12% |
| 3 Years: | 22% |
| TTM: | 20% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 29% |
| 5 Years: | 48% |
| 3 Years: | 46% |
| 1 Year: | 75% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 18% |
| 3 Years: | 15% |
| TTM: | 14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 35% |
| 5 Years: | 20% |
| 3 Years: | 21% |
| TTM: | 18% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 29% |
| 5 Years: | 48% |
| 3 Years: | 46% |
| 1 Year: | 75% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|